Sharmila Dissanaike serves as Executive at HERON THERAPEUTICS, INC. /DE/, where they oversee executive responsibilities. Since joining the company, Sharmila Dissanaike has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 30, 2026 involved receiving (via award) 53,960 shares valued at $0.
Sharmila Dissanaike currently holds 53,960 shares of HERON THERAPEUTICS, INC. /DE/ (HRTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sharmila Dissanaike has been a net neutral trader of HRTX stock. They have purchased $0 and sold $0 worth of shares.
Sharmila Dissanaike's most recent insider trade was on Jan 30, 2026, when they sold 53,960 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 16, 2022 | HRTX | $0 | Award | 38,580 | $N/A | Discretionary |
| Dec 22, 2021 | HRTX | $0 | Award | 10,452 | $N/A | Discretionary |